High-Throughput Assay for Prediction of Plasma Protein Binding
The 20 min high-throughput assay estimates the binding of drugs to human serum albumin (HSA) and a1-acid glycoprotein (AGP) to
Read moreThe 20 min high-throughput assay estimates the binding of drugs to human serum albumin (HSA) and a1-acid glycoprotein (AGP) to
Read moreRoche revealed a new collaboration agreement with Moderna to use the Elecsys® Anti-SARS-CoV-2 S antibody assay in Moderna’s COVID-19 vaccine
Read moreThe 20 min high-throughput assay estimates the binding of drugs to a1-acid glycoprotein (AGP) and is essential for predicting plasma
Read moreThe 20 min assay measures the affinity of drugs to human microsomal membranes and determines microsomal binding in stability incubation
Read morePredicting the pharmacokinetics of new chemical entities in humans is a powerful ability for drug discovery and development. Off-the-shelf Intestinal
Read moreEnzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read moreResults from the ongoing Phase I/II COVID-19 vaccine trial, led by the University of Oxford, showed the AZD1222 vaccine developed
Read more